EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    6.1.1.17 | Neoplasms |
2002062 |
Protein kinase C phosphorylates glutamyl-tRNA synthetase in rabbit reticulocytes stimulated by tumor promoting phorbol esters. |
therapeutic application
unassigned |
1
0 |
| 6.1.1.17 | Medulloblastoma |
8915893 |
Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 6.1.1.17 | Neuroblastoma |
8915893 |
Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 6.1.1.17 | Carcinoma |
9595993 |
Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. |
diagnostic usage
ongoing research
unassigned |
2
3
0 |
| 6.1.1.17 | Neoplasms |
9595993 |
Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. |
diagnostic usage
ongoing research
unassigned |
2
3
0 |
| 6.1.1.17 | Amyotrophic Lateral Sclerosis |
10805145 |
Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. |
causal interaction
unassigned |
4
0 |
| 6.1.1.17 | Epilepsy |
10805145 |
Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. |
causal interaction
unassigned |
4
0 |
| 6.1.1.17 | Neurodegenerative Diseases |
10805145 |
Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. |
causal interaction
unassigned |
4
0 |
| 6.1.1.17 | Stroke |
10805145 |
Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. |
causal interaction
unassigned |
4
0 |
| 6.1.1.17 | Neurodegenerative Diseases |
14501018 |
Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors. |
therapeutic application
unassigned |
2
0 |
